Segui
Davide Croce
Davide Croce
Director, Research Centre in Health Economics and Healthcare Management, Carlo Cattaneo University
Email verificata su liuc.it - Home page
Titolo
Citata da
Citata da
Anno
Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment
G Mauri, E Porazzi, L Cova, U Restelli, T Tondolo, M Bonfanti, A Cerri, ...
Insights into imaging 5, 209-216, 2014
1302014
The cost of HIV disease in Northern Italy: the payer's perspective
G Rizzardini, U Restelli, P Bonfanti, E Porazzi, E Ricci, L Casartelli, ...
JAIDS Journal of acquired immune deficiency syndromes 57 (3), 211-217, 2011
412011
Cost-effectiveness of a successful schistosomiasis control programme in Cambodia (1995–2006)
D Croce, E Porazzi, E Foglia, U Restelli, M Sinuon, D Socheat, ...
Acta tropica 113 (3), 279-284, 2010
352010
Change and innovation in healthcare: findings from literature
F Milella, EA Minelli, F Strozzi, D Croce
ClinicoEconomics and outcomes research, 395-408, 2021
332021
New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region …
DCGR Umberto Restelli, Francesca Scolari, Paolo Bonfanti
BMC Infectious Diseases 2015 (15), 323, 2015
28*2015
Technology assessment in hospitals: lessons learned from an empirical experiment
E Foglia, E Lettieri, L Ferrario, E Porazzi, E Garagiola, R Pagani, ...
International journal of technology assessment in health care 33 (2), 288-296, 2017
252017
Cost-utility analysis of lopinavir/ritonavir versus atazanavir+ ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial …
E Foglia, P Bonfanti, G Rizzardini, E Bonizzoni, U Restelli, E Ricci, ...
Plos one 8 (2), e57777, 2013
252013
Pressure ulcers management: an economic evaluation
E Foglia, U Restelli, AM Napoletano, D Coclite, E Porazzi, M Bonfanti, ...
Journal of preventive medicine and hygiene 53 (1), 2012
242012
Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?
G Rizzardini, U Restelli, P Bonfanti, E Porazzi, E Ricci, E Foglia, L Carenzi, ...
ClinicoEconomics and outcomes research, 245-252, 2012
232012
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study
U Restelli, GL Ceresoli, D Croce, L Evangelista, LS Maffioli, L Gianoncelli, ...
Cancer management and research, 789-800, 2017
202017
Health-technology assessment: Its role in strengthening health systems in developing countries
D Mueller, D Tivey, D Croce
Southern African Journal of Public Health 2 (1), 6-11, 2017
202017
Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic …
U Restelli, D Croce, V Pacelli, F Ciceri, C Girmenia
Infection and drug resistance, 1127-1138, 2019
192019
Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy
U Restelli, G Saibene, P Nardulli, R Di Turi, E Bonizzoni, F Scolari, ...
BMJ open 7 (7), e015645, 2017
182017
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project
M Andreoni, S Marcotullio, V Puro, G De Carli, G Tambussi, S Nozza, ...
New microbiologica 38 (4), 443-490, 2015
182015
A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation?
T Galli, P Mirata, E Foglia, D Croce, E Porazzi, L Ferrario, E Ricci, ...
ClinicoEconomics and outcomes research, 301-307, 2018
162018
A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review
J Cox, C Gutner, N Kronfli, A Lawson, M Robbins, L Nientker, A Ostawal, ...
PLoS One 14 (8), e0220060, 2019
142019
Sensitivity analysis of the material properties of different soft-tissues: implications for a subject-specific knee arthroplasty
S Pianigiani, D Croce, M D’Aiuto, W Pascale, B Innocenti
Muscles, ligaments and tendons journal 7 (4), 546, 2017
132017
Budget impact analysis of the simplification to atazanavir+ ritonavir+ lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy …
U Restelli, M Fabbiani, S Di Giambenedetto, C Nappi, D Croce
ClinicoEconomics and Outcomes Research, 173-179, 2017
122017
Cost-effectiveness analysis of the use of daclatasvir+ sofosbuvir+ ribavirin (16 weeks and 12 weeks) vs sofosbuvir+ ribavirin (16 weeks and 24 weeks) for the treatment of …
U Restelli, A Alberti, A Lazzarin, M Bonfanti, C Nappi, D Croce
The European Journal of Health Economics 19, 37-44, 2018
112018
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
U Restelli, M Andreoni, A Antinori, M Bonfanti, G Di Perri, M Galli, ...
Clinicoeconomics and outcomes research, 409-414, 2014
112014
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20